A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies
Ophélia Maertens(American Institutes for Research), Karen Cichowski(Brigham and Women's Hospital), Thomas De Raedt(Children's Hospital of Philadelphia), Mila E. McCurrach(NYU Langone Health), Timothy P. Cripe(Nationwide Children's Hospital), Kevin Shannon(City College of San Francisco), Benjamin S. Braun(Boston University), Inbal Epstein(UCSF Helen Diller Family Comprehensive Cancer Center), Nancy Ratner(Cincinnati Children's Hospital Medical Center), Jianqiang Wu(Cincinnati Children's Hospital Medical Center), Tannie Q. Huang(UCSF Helen Diller Family Comprehensive Cancer Center), Hye-Rim Lee(Chungbuk National University), D. Wade Clapp(Indiana University Health), Jennifer Lauchle(Genentech)
Cited by 25
Related Papers
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
|Cell|2015|377
Recombinant Human Erythropoietin Stimulates Erythropoiesis and Reduces Erythrocyte Transfusions in Very Low Birth Weight Preterm Infants
|PEDIATRICS|1995|323
Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors
|Cancer Discovery|2012|297
Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
|Cancer Cell|2011|259
Elucidating Distinct Roles for <i>NF1</i> in Melanomagenesis
|Cancer Discovery|2012|250